Details of the Drug Formulaction

General Information of Drug Formulation (ID: F16476)

• Formulation Name: Panobinostat 20 mg capsule
• Company: Novartis Pharmaceuticals Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Panobinostat	(DM58WKG)	Chronic graft versus host disease		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent